Navigation Links
Linden Enters Anatomic Pathology Sector Through Investment in Strata Pathology Services, Inc.
Date:7/26/2011

CHICAGO, July 26, 2011 /PRNewswire/ -- Linden LLC, a Chicago-based healthcare private equity firm, today announced that it has made an investment in Strata Pathology Services, Inc., a leading independent anatomic pathology laboratory in New England.

Headquartered in Lexington, Massachusetts, Strata offers anatomic pathology services in the dermatology, urology, podiatry, oral pathology, gastroenterology and gynecology segments. Since 1984, the company has developed proprietary knowledge, expertise and strong client relationships, and has established itself as a thought leader in the dermatopathology space.  

Linden Operating Partner Richard Novak, a 30-year veteran of the laboratory industry who previously was the chief operating officer of Laboratory Corporation of America (NYSE: LH), will serve as chairman of Strata. "The anatomic pathology market is an exciting and fast-growing segment of the lab industry, and Strata's strong position in the New England market, clinical expertise and high-quality customer service position it well for future growth," commented Novak.

Strata currently serves clients in more than 40 states and has recently added a number of international customers. With Linden's leadership, Strata will look to enhance its robust historical growth through a broadening of its testing menu and a more expansive outreach program to bring Strata's best-in-class client service and clinical expertise to a significantly wider customer base.

Robin Kirby, M.D., co-founder and medical director of Strata, added: "We are excited about our partnership with Linden during this next chapter for Strata. The expertise and capital that they bring to the table will help us to continue to bring the highest level of care to our customers and to expand our offering to many more physicians in New England and nationally."

England & Company acted as exclusive financial advisor to Strata for this transaction.

About Strata Pathology Services, Inc.

Strata is a full-service anatomic pathology laboratory. The company offers services in all areas of surgical pathology and cytology, as well as molecular diagnostics and immunofluorescence. The pathology team has members with subspecialty board certifications in dermatopathology, hematopathology, cytopathology, nuclear medicine, and clinical pathology and the majority of the pathologists have more than 20 years of medical experience. Strata serves customers that range from major regional hospitals to small independent physician practices in more than 40 states. Headquartered in Lexington, Massachusetts, with additional facilities in Cambridge, Massachusetts, the company has more than 100 employees. For additional information, please visit www.pathsrv.com.

About Linden LLC

Linden is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare and life science industries. Linden's investment strategy is based upon three elements: i) healthcare and life science industry specialization, ii) integrated private equity and operating expertise, and iii) strategic relationships with large corporations. Linden currently manages $575 million in capital. For additional information, please visit www.lindenllc.com.

Media Contact:
Caroline Grossman - 781.771.5579 - caroline.grossman@gmail.com


'/>"/>
SOURCE Linden LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. SBRT for Medically Inoperable Early Stage Lung Cancer a Key Topic for Elekta Presenters at Lung Cancer Conference
2. BioMed Realty Trust Enters Into New $750 Million Unsecured Revolving Credit Facility
3. Cord Blood America Enters Agreement With Regence, Serving BlueCross and BlueShield Programs in the Northwest U.S. and Mountain Regions
4. Cord Blood America Enters Agreement With Horizon Healthcare Services, Inc. to Offer Stem Cell Collection Services to Its Members
5. Dyadic International Enters Into Research and License Agreement With Major Player in the Animal Feed Industry
6. Sequenom Enters Into New $30.0 Million Credit Facility
7. Dyadic Netherlands Enters Into R&D Collaboration With Sanofi Pasteur and EnGen Bio
8. Sigma® Life Science Joins AMDeCs Vendor Partnership Program, Further Enhancing Value to Academic Medical Research Centers
9. TriLink Enters Into Distribution Agreement With TATAA Biocenter
10. BioNeutral Enters into Global Sales and Distribution Agreement with Raymond Associates to Expand Market for Military-Grade Ygiene(TM)
11. Pioneer® Surgical Technology, Inc. Enters the Biologics Extremities and Pelvis Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , ... June 27, 2016 , ... Parallel 6 ... trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module which ... with the physician and clinical trial team. , Using the CONSULT module, patients and ...
(Date:6/27/2016)... 27, 2016  Liquid Biotech USA ... of a Sponsored Research Agreement with The University ... (CTCs) from cancer patients.  The funding will be ... correlate with clinical outcomes in cancer patients undergoing ... then be employed to support the design of ...
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a ... eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research ... by providing practical tips, tools, and strategies for clinical researchers. , “The landscape ...
Breaking Biology Technology:
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
(Date:4/28/2016)... Sweden , April 28, 2016 First ... M (139.9), up 966% compared with the first quarter of 2015 ... profit totaled SEK 589.1 M (loss: 18.8) and the operating margin ... 7.12 (loss: 0.32) Cash flow from operations was SEK ... The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/19/2016)... 2016 The new GEZE SecuLogic ... web-based "all-in-one" system solution for all door components. It ... the door interface with integration authorization management system, and ... The minimal dimensions of the access control and the ... installations offer considerable freedom of design with regard to ...
Breaking Biology News(10 mins):